Vinblastine sulfate - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for vinblastine sulfate and what is the scope of freedom to operate?
Vinblastine sulfate
is the generic ingredient in two branded drugs marketed by Lilly, Abraxis Pharm, Fresenius Kabi Usa, Hikma, and Hospira, and is included in five NDAs. Additional information is available in the individual branded drug profile pages.There are four drug master file entries for vinblastine sulfate. One supplier is listed for this compound.
Summary for vinblastine sulfate
US Patents: | 0 |
Tradenames: | 2 |
Applicants: | 5 |
NDAs: | 5 |
Drug Master File Entries: | 4 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 52 |
Clinical Trials: | 71 |
Patent Applications: | 7,505 |
What excipients (inactive ingredients) are in vinblastine sulfate? | vinblastine sulfate excipients list |
DailyMed Link: | vinblastine sulfate at DailyMed |
Recent Clinical Trials for vinblastine sulfate
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Hospital Universitario Dr. Jose E. Gonzalez | Phase 2 |
University of Washington | Phase 2 |
AstraZeneca | Phase 2 |
Pharmacology for vinblastine sulfate
Drug Class | Vinca Alkaloid |
Medical Subject Heading (MeSH) Categories for vinblastine sulfate
Anatomical Therapeutic Chemical (ATC) Classes for vinblastine sulfate
US Patents and Regulatory Information for vinblastine sulfate
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hikma | VINBLASTINE SULFATE | vinblastine sulfate | INJECTABLE;INJECTION | 089395-001 | Apr 9, 1987 | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Abraxis Pharm | VINBLASTINE SULFATE | vinblastine sulfate | INJECTABLE;INJECTION | 089011-001 | Nov 18, 1985 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Fresenius Kabi Usa | VINBLASTINE SULFATE | vinblastine sulfate | INJECTABLE;INJECTION | 089515-001 | Apr 29, 1987 | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Lilly | VELBAN | vinblastine sulfate | INJECTABLE;INJECTION | 012665-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Hospira | VINBLASTINE SULFATE | vinblastine sulfate | INJECTABLE;INJECTION | 089565-001 | Aug 18, 1987 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.